Report Tools

Biotechnology in Japan

Published: August 2013 · Publisher: MarketLine
Biotechnology in Japan industry profile provides top-line qualitative and quantitative summary information including: market size (value 2008-12, and forecast to 2017).
Report Type Industry Profiles
Language English
Format Electronic (PDF)
Pages35
Frequency Updated Annually
Availability Will be emailed within 1 business day
Reference No. 0109-6783
Price € 259,00
Options
  • Description
  • Companies Mentioned
  • Table of Contents
  • Ask a Question
Introduction

Biotechnology in Japan industry profile provides top-line qualitative and quantitative summary information including: market size (value 2008-12, and forecast to 2017). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Japan biotechnology market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Highlights

*The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.

*The Japanese biotechnology market had total revenues of $43.3bn in 2012, representing a compound annual growth rate (CAGR) of 3.8% between 2008 and 2012.

*The competitiveness of the Japanese biotechnology industry is underpinned by the country’s high share of biotechnology patents filed under primary care trust and the high amount of biotechnology R&D expenditures in the business sector.

*The performance of the market is forecast to accelerate, with an anticipated CAGR of 4.4% for the five-year period 2012 - 2017, which is expected to drive the market to a value of $53.8bn by the end of 2017.

Features

Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Japan

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Japan

Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the Japan biotechnology market with five year forecasts

Macroeconomic indicators provide insight into general trends within the Japan economy

Key Questions Answered

What was the size of the Japan biotechnology market by value in 2012?

What will be the size of the Japan biotechnology market in 2017?

What factors are affecting the strength of competition in the Japan biotechnology market?

How has the market performed over the last five years?

What are the main segments that make up Japan's biotechnology market?
Copyright © FriedlNet. You may share using our tools Please don't cut content from FriedlNet and redistribute by email or post to the web.
Astellas Pharma Inc., Daiichi Sankyo Co., Ltd., Mitsubishi Tanabe Pharma Corporation and Takeda Pharmaceutical Company Limited
TABLE OF CONTENTS
Executive Summary 2
Market value 2
Market value forecast 2
Category segmentation 2
Geography segmentation 2
Market rivalry 2
Market Overview 7
Market definition 7
Market analysis 7
Market Data 8
Market value 8
Market Segmentation 9
Category segmentation 9
Geography segmentation 10
Market Outlook 11
Market value forecast 11
Five Forces Analysis 12
Summary 12
Buyer power 13
Supplier power 14
New entrants 15
Threat of substitutes 17
Degree of rivalry 18
Leading Companies 19
Astellas Pharma Inc. 19
Daiichi Sankyo Co., Ltd. 22
Mitsubishi Tanabe Pharma Corporation 25
Takeda Pharmaceutical Company Limited 28
Macroeconomic Indicators 31
Country Data 31
Appendix 33
Methodology 33
Industry associations 34
Related research 34

LIST OF TABLES
Table 1: Japan biotechnology market value: $ billion, 2008–12 8
Table 2: Japan biotechnology market category segmentation: $ billion, 2012 9
Table 3: Japan biotechnology market geography segmentation: $ billion, 2012 10
Table 4: Japan biotechnology market value forecast: $ billion, 2012–17 11
Table 5: Astellas Pharma Inc.: key facts 19
Table 6: Astellas Pharma Inc.: key financials ($) 20
Table 7: Astellas Pharma Inc.: key financials (¥) 20
Table 8: Astellas Pharma Inc.: key financial ratios 20
Table 9: Daiichi Sankyo Co., Ltd.: key facts 22
Table 10: Daiichi Sankyo Co., Ltd.: key financials ($) 22
Table 11: Daiichi Sankyo Co., Ltd.: key financials (¥) 23
Table 12: Daiichi Sankyo Co., Ltd.: key financial ratios 23
Table 13: Mitsubishi Tanabe Pharma Corporation: key facts 25
Table 14: Mitsubishi Tanabe Pharma Corporation: key financials ($) 25
Table 15: Mitsubishi Tanabe Pharma Corporation: key financials (¥) 26
Table 16: Mitsubishi Tanabe Pharma Corporation: key financial ratios 26
Table 17: Takeda Pharmaceutical Company Limited: key facts 28
Table 18: Takeda Pharmaceutical Company Limited: key financials ($) 29
Table 19: Takeda Pharmaceutical Company Limited: key financials (¥) 29
Table 20: Takeda Pharmaceutical Company Limited: key financial ratios 29
Table 21: Japan size of population (million), 2008–12 31
Table 22: Japan gdp (constant 2000 prices, $ billion), 2008–12 31
Table 23: Japan gdp (current prices, $ billion), 2008–12 31
Table 24: Japan inflation, 2008–12 32
Table 25: Japan consumer price index (absolute), 2008–12 32
Table 26: Japan exchange rate, 2008–12 32

LIST OF FIGURES
Figure 1: Japan biotechnology market value: $ billion, 2008–12 8
Figure 2: Japan biotechnology market category segmentation: % share, by value, 2012 9
Figure 3: Japan biotechnology market geography segmentation: % share, by value, 2012 10
Figure 4: Japan biotechnology market value forecast: $ billion, 2012–17 11
Figure 5: Forces driving competition in the biotechnology market in Japan, 2012 12
Figure 6: Drivers of buyer power in the biotechnology market in Japan, 2012 13
Figure 7: Drivers of supplier power in the biotechnology market in Japan, 2012 14
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology market in Japan, 2012 15
Figure 9: Factors influencing the threat of substitutes in the biotechnology market in Japan, 2012 17
Figure 10: Drivers of degree of rivalry in the biotechnology market in Japan, 2012 18
Figure 11: Astellas Pharma Inc.: revenues & profitability 21
Figure 12: Astellas Pharma Inc.: assets & liabilities 21
Figure 13: Daiichi Sankyo Co., Ltd.: revenues & profitability 23
Figure 14: Daiichi Sankyo Co., Ltd.: assets & liabilities 24
Figure 15: Mitsubishi Tanabe Pharma Corporation: revenues & profitability 26
Figure 16: Mitsubishi Tanabe Pharma Corporation: assets & liabilities 27
Figure 17: Takeda Pharmaceutical Company Limited: revenues & profitability 30
Figure 18: Takeda Pharmaceutical Company Limited: assets & liabilities 30
Copyright © FriedlNet. You may share using our tools Please don't cut content from FriedlNet and redistribute by email or post to the web.